Delivery Order SPE2DE24DA017-SPE2D626F8688
- Not listed
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $2,597.76 by the Defense Logistics Agency's Medical Supply Chain on September 10, 2025. This fixed-price delivery order with economic price adjustment is for an ANGEL CPRP (Autologous Neovasculogenic Growth Factor) Processing Set and does not utilize a set-aside designation. The contract is to be completed by September 15, 2025, with performance occurring...
- Arthrex Inc., headquartered in Naples, Florida, has been awarded a delivery order valued at $3,241.26 for an Angel CPRP Processing Set under a fixed-price contract with economic price adjustment provisions. The award, issued on October 23, 2025, with an ultimate completion date of October 28, 2025, is funded through the Defense Logistics Agency's Medical Supply Chain, a division supporting orthopedic procurement for the Department of Defense and Department of Veterans Affairs. This delivery...
- Arthrex Inc., a global leader in minimally invasive orthopedic medical technologies headquartered in Naples, Florida, has received a delivery order valued at $2,597.76 from the Defense Logistics Agency's Medical Supply Chain for an ANGEL CPRP (Cellular Platelet-Rich Plasma) Processing Set. Awarded on June 6, 2025, with an ultimate completion date of June 11, 2025, this fixed-price delivery order with economic price adjustment carries no set-aside designation, reflecting Arthrex's strong...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $12,489.84 by the Defense Logistics Agency's Medical Supply Chain on August 26, 2025. The contract, which is a fixed-price delivery order with economic price adjustment provisions, calls for the delivery of an ANGEL CPRP Processing Set USM and is scheduled for completion by August 29, 2025. This award was made without a set-aside designation, reflecting...
- Arthrex Inc., headquartered in Naples, Florida, has been awarded a delivery order valued at $4,952.90 by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency. The contract, which is not set aside for any specific business type, is structured as a fixed-price agreement with economic price adjustment provisions. The delivery order was executed on July 31, 2025, with an ultimate completion date of August 5, 2025, and will be performed at Arthrex's Naples, Florida...
- Arthrex Inc., a Naples, Florida-based orthopedic medical device manufacturer, was awarded a $3,577.20 fixed-price delivery order with economic price adjustment on July 29, 2025, by the Defense Logistics Agency's Medical Supply Chain. The contract, which carries an ultimate completion date of August 4, 2025, covers a Centerline Sterilized Disposable Arthroscopy Angel Lift Platelet kit and represents performance in Naples, Florida. This award was not set aside for any specific business type,...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $1,353.00 by the Defense Logistics Agency's Medical Supply Chain on July 31, 2025. The contract, which is a fixed-price delivery order with economic price adjustment provisions, calls for the delivery of an ACD-A 8G Open Tip BMA Angel Kit to be completed by August 8, 2025, and will be performed in Naples, Florida. This award represents a task order under...
- Arthrex Inc., a leading global manufacturer of minimally invasive orthopedic medical technologies headquartered in Naples, Florida, was awarded a delivery order valued at $3,235.68 on July 31, 2025, by the Defense Logistics Agency's Medical Supply Chain. The delivery order, designated as a fixed-price contract with economic price adjustment provisions, calls for delivery of an Angel System with Aspiration Kit and ACDA components to be completed by August 5, 2025. The contract was executed...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, received a fixed-price delivery order valued at $3,577.20 from the Defense Logistics Agency's Medical Supply Chain on August 1, 2025, with an ultimate completion date of August 6, 2025. The delivery order covers the Arthrex ANGEL PRP Kit for the U.S. market, a specialized medical device used in orthopedic procedures. This award was not set aside for any specific business category, reflecting...
- Arthrex Inc., a Naples, Florida-based leader in minimally invasive orthopedic medical technologies, was awarded a delivery order valued at $24,508.61 on September 25, 2025, by the Defense Logistics Agency's Medical Supply Chain. This fixed-price delivery order with economic price adjustment is scheduled for completion by September 30, 2025, and represents performance work to be conducted in Naples, Florida. The award was made without a set-aside designation, demonstrating Arthrex's competitive...
- SPE2DE24DA017Indefinite Delivery Contract
- SPE2DE24DA017-SPE2D626F8688Delivery Order
Arthrex Inc., headquartered in Naples, Florida, has been awarded a delivery order valued at $5,195.52 for an Angel CPRP Processing Set under the Defense Logistics Agency's Medical Supply Chain program. This fixed-price delivery order with economic price adjustment authority was issued on November 3, 2025, with an ultimate completion date of November 6, 2025. The award carries no set-aside designation, reflecting Arthrex's competitive position as a sole-source supplier for specialized orthopedic medical technologies. Performance will be completed at the company's Naples, Florida facility. This delivery order is issued under Arthrex's existing indefinite delivery contract SPE2DE24D0020 with the Defense Logistics Agency, a comprehensive master contract valued at $471 billion effective through September 2029 that authorizes procurement of orthopedic products and surgical technologies supporting Department of Veterans Affairs medical centers and Department of Defense healthcare facilities nationwide. As the prime contractor with no identified subcontractors, Arthrex continues to serve as a primary supplier of minimally invasive orthopedic surgical instruments, implants, and biologics directly to federal healthcare enterprise customers across multiple orthopedic specialties.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 11/3/25 |